サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1373460

皮内注射器の世界市場の考察、予測（～2029年）

Global Intradermal Injection Device Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 139 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
皮内注射器の世界市場の考察、予測（～2029年）
出版日: 2023年11月06日
発行: QYResearch
ページ情報: 英文 139 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の皮内注射器の市場規模は、2023年に1億910万米ドル、2029年までに1億3,775万米ドルに達し、予測期間にCAGRで3.96％の成長が予測されています。

米国・カナダ市場は2023年に1,979万米ドル、2029年までに2,409万米ドルに達すると推定され、2023年～2029年の予測期間のCAGRは3.33%です。

中国市場は2023年に1,564万米ドル、2029年までに2,351万米ドルに達すると推定され、予測期間のCAGRは7.03％です。

欧州市場は2023年に2,282万米ドル、2029年までに2,816万米ドルに達すると推定され、予測期間のCAGRは3.56％です。

当レポートでは、世界の皮内注射器市場について調査分析し、各地域の市場規模と予測、市場力学、競合情勢などを提供しています。

目次

第1章 調査範囲

  • 皮内注射器製品のイントロダクション
  • 市場：タイプ別
    • 世界の皮内注射器の市場規模成長率：タイプ別（2018年・2022年・2029年）
    • 使い捨て
    • 再使用可能
  • 市場：用途別
    • 世界の皮内注射器の市場規模成長率：用途別（2018年・2022年・2029年）
    • ワクチン
    • 医学的検査
    • その他
  • 前提条件と制限
  • 調査目的
  • 考慮された年数

第2章 エグゼクティブサマリー

  • 世界の皮内注射器の収益の推計と予測（2018年～2029年）
  • 世界の皮内注射器の収益：地域別
    • 世界の皮内注射器の収益：地域別（2018年・2022年・2029年）
    • 世界の皮内注射器の収益：地域別（2018年～2023年）
    • 世界の皮内注射器の収益：地域別（2024年～2029年）
    • 世界の皮内注射器の収益の市場シェア：地域別（2018年～2029年）
  • 世界の皮内注射器の売上の推計と予測（2018年～2029年）
  • 世界の皮内注射器の売上：地域別
    • 世界の皮内注射器の売上：地域別（2018年・2022年・2029年）
    • 世界の皮内注射器の売上：地域別（2018年～2023年）
    • 世界の皮内注射器の売上：地域別（2024年～2029年）
    • 世界の皮内注射器の売上の市場シェア：地域別（2018年～2029年）
  • 米国・カナダ
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合：メーカー別

  • 世界の皮内注射器の売上：メーカー別
    • 世界の皮内注射器の売上：メーカー別（2018年～2023年）
    • 世界の皮内注射器の売上の市場シェア：メーカー別（2018年～2023年）
    • 世界の皮内注射器の3大・5大メーカー（2022年）
  • 世界の皮内注射器の収益：メーカー別
    • 世界の皮内注射器の収益：メーカー別（2018年～2023年）
    • 世界の皮内注射器の収益の市場シェア：メーカー別（2018年～2023年）
    • 世界の皮内注射器の収益の3大・5大メーカー（2022年）
  • 世界の皮内注射器の主要企業、産業ランキング（2021年・2022年）
  • 世界の皮内注射器の販売価格：メーカー別（2018年～2023年）
  • 競合情勢の分析
    • メーカーの市場集中度（CR5とHHI）
    • 世界の皮内注射器の市場シェア：企業タイプ別（Tier 1・Tier 2・Tier 3）
  • 世界の皮内注射器の主要メーカー、製造拠点の分布、本社
  • 世界の皮内注射器の主要メーカー、提供製品、用途
  • 世界の皮内注射器の主要メーカー、業界参入日
  • 合併と買収、拡張計画

第4章 市場規模：タイプ別

  • 世界の皮内注射器の売上：タイプ別
    • 世界の皮内注射器の売上の実績：タイプ別（2018年～2023年）
    • 世界の皮内注射器の売上の予測：タイプ別（2024年～2029年）
    • 世界の皮内注射器の売上の市場シェア：タイプ別（2018年～2029年）
  • 世界の皮内注射器の収益：タイプ別
    • 世界の皮内注射器の収益の実績：タイプ別（2018年～2023年）
    • 世界の皮内注射器の収益の予測：タイプ別（2024年～2029年）
    • 世界の皮内注射器の収益の市場シェア：タイプ別（2018年～2029年）
  • 世界の皮内注射器の価格：タイプ別
    • 世界の皮内注射器の価格：タイプ別（2018年～2023年）
    • 世界の皮内注射器の価格の予測：タイプ別（2024年～2029年）

第5章 市場規模：用途別

  • 世界の皮内注射器の売上：用途別
    • 世界の皮内注射器の売上の実績：用途別（2018年～2023年）
    • 世界の皮内注射器の売上の予測：用途別（2024年～2029年）
    • 世界の皮内注射器の売上の市場シェア：用途別（2018年～2029年）
  • 世界の皮内注射器の収益：用途別
    • 世界の皮内注射器の収益の実績：用途別（2018年～2023年）
    • 世界の皮内注射器の収益の予測：用途別（2024年～2029年）
    • 世界の皮内注射器の収益の市場シェア：用途別（2018年～2029年）
  • 世界の皮内注射器の価格：用途別
    • 世界の皮内注射器の価格：用途別（2018年～2023年）
    • 世界の皮内注射器の価格の予測：用途別（2024年～2029年）

第6章 米国・カナダ

  • 米国・カナダの皮内注射器の市場規模：タイプ別
    • 米国・カナダの皮内注射器の売上：タイプ別（2018年～2029年）
    • 米国・カナダの皮内注射器の収益：タイプ別（2018年～2029年）
  • 米国・カナダの皮内注射器の市場規模：用途別
    • 米国・カナダの皮内注射器の売上：用途別（2018年～2029年）
    • 米国・カナダの皮内注射器の収益：用途別（2018年～2029年）
  • 米国・カナダの皮内注射器の市場規模：国別
    • 米国・カナダの皮内注射器の収益：国別（2018年・2022年・2029年）
    • 米国・カナダの皮内注射器の収益：国別（2018年～2029年）
    • 米国・カナダの皮内注射器の売上：国別（2018年～2029年）
    • 米国
    • カナダ

第7章 欧州

  • 欧州の皮内注射器の市場規模：タイプ別
    • 欧州の皮内注射器の売上：タイプ別（2018年～2029年）
    • 欧州の皮内注射器の収益：タイプ別（2018年～2029年）
  • 欧州の皮内注射器の市場規模：用途別
    • 欧州の皮内注射器の売上：用途別（2018年～2029年）
    • 欧州の皮内注射器の売上：用途別（2018年～2029年）
  • 欧州の皮内注射器の市場規模：国別
    • 欧州の皮内注射器の収益：国別（2018年・2022年・2029年）
    • 欧州の皮内注射器の収益：国別（2018年～2029年）
    • 欧州の皮内注射器の売上：国別（2018年～2029年）
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋の皮内注射器の市場規模：タイプ別
    • アジア太平洋の皮内注射器の売上：タイプ別（2018年～2029年）
    • アジア太平洋の皮内注射器の収益：タイプ別（2018年～2029年）
  • アジア太平洋の皮内注射器の市場規模：用途別
    • アジア太平洋の皮内注射器の売上：用途別（2018年～2029年）
    • アジア太平洋の皮内注射器の収益：用途別（2018年～2029年）
  • アジア太平洋の皮内注射器の市場規模：地域別
    • アジア太平洋の皮内注射器の収益（2018年・2022年・2029年）
    • アジア太平洋の皮内注射器の収益：地域別（2018年～2029年）
    • アジア太平洋の皮内注射器の売上：地域別（2018年～2029年）
    • 中国
    • 日本
    • 韓国
    • インド
    • アジア太平洋

第9章 ラテンアメリカ

  • ラテンアメリカの皮内注射器の市場規模：タイプ別
    • ラテンアメリカの皮内注射器の売上：タイプ別（2018年～2029年）
    • ラテンアメリカの皮内注射器の収益：タイプ別（2018年～2029年）
  • ラテンアメリカの皮内注射器の市場規模：用途別
    • ラテンアメリカの皮内注射器の売上：用途別（2018年～2029年）
    • ラテンアメリカの皮内注射器の収益：用途別（2018年～2029年）
  • ラテンアメリカの皮内注射器の市場規模：地域別
    • ラテンアメリカの皮内注射器の収益：地域別（2018年・2022年・2029年）
    • ラテンアメリカの皮内注射器の収益：国別（2018年～2029年）
    • ラテンアメリカの皮内注射器の売上：国別（2018年～2029年）
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの皮内注射器の市場規模：タイプ別
    • 中東・アフリカの皮内注射器の売上：タイプ別（2018年～2029年）
    • 中東・アフリカの皮内注射器の収益：タイプ別（2018年～2029年）
  • 中東・アフリカの皮内注射器の市場規模：用途別
    • 中東・アフリカの皮内注射器の売上：用途別（2018年～2029年）
    • 中東・アフリカの皮内注射器の収益：用途別（2018年～2029年）
  • 中東・アフリカの皮内注射器の市場規模：地域別
    • 中東・アフリカの皮内注射器の収益：地域別（2018年・2022年・2029年）
    • 中東・アフリカの皮内注射器の収益：国別（2018年～2029年）
    • 中東・アフリカの皮内注射器の売上：国別（2018年～2029年）
    • 中東
    • アフリカ

第11章 企業プロファイル

  • BD
  • Terumo
  • HIPRA
  • NanoPass Technologies
  • Novosanis (Idevax)
  • Idevax
  • PharmaJet
  • Debiotech
  • Lightnix Inc

第12章 産業チェーンと販売チャネルの分析

  • 皮内注射器の産業チェーン分析
  • 皮内注射器の主な原材料
    • 主な原材料
    • 原材料の主要サプライヤー
  • 皮内注射器の生産方式とプロセス
  • 皮内注射器の販売とマーケティング
    • 皮内注射器の販売業者
  • 皮内注射器の顧客

第13章 皮内注射器の市場力学

    • 皮内注射器産業の動向
    • 皮内注射器市場の促進要因
    • 皮内注射器市場の課題
    • 皮内注射器市場の抑制要因

第14章 世界の皮内注射器研究における主な発見

第15章 付録

図表

List of Tables

  • Table 1. Global Intradermal Injection Device Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Reusable
  • Table 3. Global Intradermal Injection Device Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 4. Global Intradermal Injection Device Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Intradermal Injection Device Revenue by Region (2018-2023) & (US$ Million)
  • Table 6. Global Intradermal Injection Device Revenue by Region (2024-2029) & (US$ Million)
  • Table 7. Global Intradermal Injection Device Revenue Market Share by Region (2018-2023)
  • Table 8. Global Intradermal Injection Device Revenue Market Share by Region (2024-2029)
  • Table 9. Global Intradermal Injection Device Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (K Units)
  • Table 10. Global Intradermal Injection Device Sales by Region (2018-2023) & (K Units)
  • Table 11. Global Intradermal Injection Device Sales by Region (2024-2029) & (K Units)
  • Table 12. Global Intradermal Injection Device Sales Market Share by Region (2018-2023)
  • Table 13. Global Intradermal Injection Device Sales Market Share by Region (2024-2029)
  • Table 14. Global Intradermal Injection Device Sales by Manufacturers (2018-2023) & (K Units)
  • Table 15. Global Intradermal Injection Device Sales Share by Manufacturers (2018-2023)
  • Table 16. Global Intradermal Injection Device Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 17. Global Intradermal Injection Device Revenue Market Share by Manufacturers (2018-2023)
  • Table 18. Global Key Players of Intradermal Injection Device, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 19. Intradermal Injection Device Price by Manufacturers (2018-2023) & (US$/K Units)
  • Table 20. Global Intradermal Injection Device Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 21. Global Intradermal Injection Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intradermal Injection Device as of 2022)
  • Table 22. Global Key Manufacturers of Intradermal Injection Device, Manufacturing Base Distribution and Headquarters
  • Table 23. Global Key Manufacturers of Intradermal Injection Device, Product Offered and Application
  • Table 24. Global Key Manufacturers of Intradermal Injection Device, Date of Enter into This Industry
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 27. Global Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 28. Global Intradermal Injection Device Sales Share by Type (2018-2023)
  • Table 29. Global Intradermal Injection Device Sales Share by Type (2024-2029)
  • Table 30. Global Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 31. Global Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 32. Global Intradermal Injection Device Revenue Share by Type (2018-2023)
  • Table 33. Global Intradermal Injection Device Revenue Share by Type (2024-2029)
  • Table 34. Intradermal Injection Device Price by Type (2018-2023) & (US$/K Units)
  • Table 35. Global Intradermal Injection Device Price Forecast by Type (2024-2029) & (US$/K Units)
  • Table 36. Global Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 37. Global Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 38. Global Intradermal Injection Device Sales Share by Application (2018-2023)
  • Table 39. Global Intradermal Injection Device Sales Share by Application (2024-2029)
  • Table 40. Global Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 41. Global Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 42. Global Intradermal Injection Device Revenue Share by Application (2018-2023)
  • Table 43. Global Intradermal Injection Device Revenue Share by Application (2024-2029)
  • Table 44. Intradermal Injection Device Price by Application (2018-2023) & (US$/K Units)
  • Table 45. Global Intradermal Injection Device Price Forecast by Application (2024-2029) & (US$/K Units)
  • Table 46. US & Canada Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 47. US & Canada Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 48. US & Canada Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 49. US & Canada Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 50. US & Canada Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 51. US & Canada Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 52. US & Canada Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 53. US & Canada Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 54. US & Canada Intradermal Injection Device Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 55. US & Canada Intradermal Injection Device Revenue by Country (2018-2023) & (US$ Million)
  • Table 56. US & Canada Intradermal Injection Device Revenue by Country (2024-2029) & (US$ Million)
  • Table 57. US & Canada Intradermal Injection Device Sales by Country (2018-2023) & (K Units)
  • Table 58. US & Canada Intradermal Injection Device Sales by Country (2024-2029) & (K Units)
  • Table 59. Europe Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 60. Europe Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 61. Europe Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 62. Europe Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 63. Europe Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 64. Europe Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 65. Europe Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 66. Europe Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 67. Europe Intradermal Injection Device Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 68. Europe Intradermal Injection Device Revenue by Country (2018-2023) & (US$ Million)
  • Table 69. Europe Intradermal Injection Device Revenue by Country (2024-2029) & (US$ Million)
  • Table 70. Europe Intradermal Injection Device Sales by Country (2018-2023) & (K Units)
  • Table 71. Europe Intradermal Injection Device Sales by Country (2024-2029) & (K Units)
  • Table 72. Asia-Pacific Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 73. Asia-Pacific Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 74. Asia-Pacific Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 75. Asia-Pacific Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 76. Asia-Pacific Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 77. Asia-Pacific Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 78. Asia-Pacific Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 79. Asia-Pacific Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 80. Asia-Pacific Intradermal Injection Device Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 81. Asia-Pacific Intradermal Injection Device Revenue by Region (2018-2023) & (US$ Million)
  • Table 82. Asia-Pacific Intradermal Injection Device Revenue by Region (2024-2029) & (US$ Million)
  • Table 83. Asia-Pacific Intradermal Injection Device Sales by Region (2018-2023) & (K Units)
  • Table 84. Asia-Pacific Intradermal Injection Device Sales by Region (2024-2029) & (K Units)
  • Table 85. Latin America Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 86. Latin America Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 87. Latin America Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 88. Latin America Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 89. Latin America Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 90. Latin America Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 91. Latin America Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 92. Latin America Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 93. Latin America Intradermal Injection Device Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 94. Latin America Intradermal Injection Device Revenue by Region (2018-2023) & (US$ Million)
  • Table 95. Latin America Intradermal Injection Device Revenue by Region (2024-2029) & (US$ Million)
  • Table 96. Latin America Intradermal Injection Device Sales by Country (2018-2023) & (K Units)
  • Table 97. Latin America Intradermal Injection Device Sales by Country (2024-2029) & (K Units)
  • Table 98. Middle East and Africa Intradermal Injection Device Sales by Type (2018-2023) & (K Units)
  • Table 99. Middle East and Africa Intradermal Injection Device Sales by Type (2024-2029) & (K Units)
  • Table 100. Middle East and Africa Intradermal Injection Device Revenue by Type (2018-2023) & (US$ Million)
  • Table 101. Middle East and Africa Intradermal Injection Device Revenue by Type (2024-2029) & (US$ Million)
  • Table 102. Middle East and Africa Intradermal Injection Device Sales by Application (2018-2023) & (K Units)
  • Table 103. Middle East and Africa Intradermal Injection Device Sales by Application (2024-2029) & (K Units)
  • Table 104. Middle East and Africa Intradermal Injection Device Revenue by Application (2018-2023) & (US$ Million)
  • Table 105. Middle East and Africa Intradermal Injection Device Revenue by Application (2024-2029) & (US$ Million)
  • Table 106. Middle East and Africa Intradermal Injection Device Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 107. Middle East and Africa Intradermal Injection Device Revenue by Region (2018-2023) & (US$ Million)
  • Table 108. Middle East and Africa Intradermal Injection Device Revenue by Region (2024-2029) & (US$ Million)
  • Table 109. Middle East and Africa Intradermal Injection Device Sales by Country (2018-2023) & (K Units)
  • Table 110. Middle East and Africa Intradermal Injection Device Sales by Country (2024-2029) & (K Units)
  • Table 111. BD Company Information
  • Table 112. BD Description and Major Businesses
  • Table 113. BD Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 114. BD Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. BD Recent Developments
  • Table 116. Terumo Company Information
  • Table 117. Terumo Description and Major Businesses
  • Table 118. Terumo Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 119. Terumo Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. Terumo Recent Developments
  • Table 121. HIPRA Company Information
  • Table 122. HIPRA Description and Major Businesses
  • Table 123. HIPRA Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 124. HIPRA Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. HIPRA Recent Developments
  • Table 126. NanoPass Technologies Company Information
  • Table 127. NanoPass Technologies Description and Major Businesses
  • Table 128. NanoPass Technologies Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 129. NanoPass Technologies Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. NanoPass Technologies Recent Developments
  • Table 131. Novosanis Company Information
  • Table 132. Novosanis (Idevax) Description and Major Businesses
  • Table 133. Novosanis (Idevax) Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 134. Novosanis (Idevax) Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. Novosanis (Idevax) Recent Developments
  • Table 136. Idevax Company Information
  • Table 137. Idevax Description and Major Businesses
  • Table 138. Idevax Recent Developments
  • Table 139. PharmaJet Company Information
  • Table 140. PharmaJet Description and Major Businesses
  • Table 141. PharmaJet Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 142. PharmaJet Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 143. PharmaJet Recent Developments
  • Table 144. Debiotech Company Information
  • Table 145. Debiotech Description and Major Businesses
  • Table 146. Debiotech Intradermal Injection Device Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2018-2023)
  • Table 147. Debiotech Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 148. Lightnix Inc Company Information
  • Table 149. Lightnix Inc Description and Major Businesses
  • Table 150. Lightnix Inc Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. Key Raw Materials Lists
  • Table 152. Raw Materials Key Suppliers Lists
  • Table 153. Intradermal Injection Device Distributors List
  • Table 154. Intradermal Injection Device Customers List
  • Table 155. Intradermal Injection Device Market Trends
  • Table 156. Intradermal Injection Device Market Drivers
  • Table 157. Intradermal Injection Device Market Challenges
  • Table 158. Intradermal Injection Device Market Restraints
  • Table 159. Research Programs/Design for This Report
  • Table 160. Key Data Information from Secondary Sources
  • Table 161. Key Data Information from Primary Sources
  • Table 162. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Intradermal Injection Device Product Picture
  • Figure 2. Global Intradermal Injection Device Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Intradermal Injection Device Market Share by Type: 2022 & 2029
  • Figure 4. Disposable Product Picture
  • Figure 5. Major Manufacturers of Disposable
  • Figure 6. Reusable Product Picture
  • Figure 7. Global Intradermal Injection Device Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 8. Global Intradermal Injection Device Market Share by Application: 2022 & 2029
  • Figure 9. Vaccine
  • Figure 10. Medical Test
  • Figure 11. Intradermal Injection Device Report Years Considered
  • Figure 12. Global Intradermal Injection Device Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 13. Global Intradermal Injection Device Revenue 2018-2029 (US$ Million)
  • Figure 14. Global Intradermal Injection Device Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 15. Global Intradermal Injection Device Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 16. Global Intradermal Injection Device Revenue Market Share by Region (2018-2029)
  • Figure 17. Global Intradermal Injection Device Sales 2018-2029 (K Units)
  • Figure 18. Global Intradermal Injection Device Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (K Units)
  • Figure 19. Global Intradermal Injection Device Sales Market Share by Region (2018-2029)
  • Figure 20. US & Canada Intradermal Injection Device Sales YoY (2018-2029) & (K Units)
  • Figure 21. US & Canada Intradermal Injection Device Revenue YoY (2018-2029) & (US$ Million)
  • Figure 22. Europe Intradermal Injection Device Sales YoY (2018-2029) & (K Units)
  • Figure 23. Europe Intradermal Injection Device Revenue YoY (2018-2029) & (US$ Million)
  • Figure 24. Asia-Pacific Intradermal Injection Device Sales YoY (2018-2029) & (K Units)
  • Figure 25. Asia-Pacific Intradermal Injection Device Revenue YoY (2018-2029) & (US$ Million)
  • Figure 26. Latin America Intradermal Injection Device Sales YoY (2018-2029) & (K Units)
  • Figure 27. Latin America Intradermal Injection Device Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. Middle East & Africa Intradermal Injection Device Sales YoY (2018-2029) & (K Units)
  • Figure 29. Middle East & Africa Intradermal Injection Device Revenue YoY (2018-2029) & (US$ Million)
  • Figure 30. The Intradermal Injection Device Market Share of Top 3 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 31. The Top 5 and 10 Largest Manufacturers of Intradermal Injection Device in the World: Market Share by Intradermal Injection Device Revenue in 2022
  • Figure 32. Global Intradermal Injection Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 33. Global Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 34. Global Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 35. Global Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 36. Global Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 37. US & Canada Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 38. US & Canada Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 39. US & Canada Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 40. US & Canada Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 41. US & Canada Intradermal Injection Device Revenue Share by Country (2018-2029)
  • Figure 42. US & Canada Intradermal Injection Device Sales Share by Country (2018-2029)
  • Figure 43. US Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 44. Canada Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 45. Europe Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 46. Europe Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 47. Europe Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 48. Europe Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 49. Europe Intradermal Injection Device Revenue Share by Country (2018-2029)
  • Figure 50. Europe Intradermal Injection Device Sales Share by Country (2018-2029)
  • Figure 51. Germany Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 52. France Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 53. U.K. Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 54. Italy Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 55. Russia Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 56. Asia-Pacific Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 57. Asia-Pacific Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 58. Asia-Pacific Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 59. Asia-Pacific Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 60. Asia-Pacific Intradermal Injection Device Revenue Share by Region (2018-2029)
  • Figure 61. Asia-Pacific Intradermal Injection Device Sales Share by Region (2018-2029)
  • Figure 62. China Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 63. Japan Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 64. South Korea Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 65. India Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 66. Southeast Asia-Pacific Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 67. Latin America Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 68. Latin America Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 69. Latin America Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 70. Latin America Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 71. Latin America Intradermal Injection Device Revenue Share by Region (2018-2029)
  • Figure 72. Latin America Intradermal Injection Device Sales Share by Region (2018-2029)
  • Figure 73. Mexico Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 74. Brazil Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 75. Middle East and Africa Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • Figure 76. Middle East and Africa Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • Figure 77. Middle East and Africa Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • Figure 78. Middle East and Africa Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • Figure 79. Middle East and Africa Intradermal Injection Device Revenue Share by Region (2018-2029)
  • Figure 80. Middle East and Africa Intradermal Injection Device Sales Share by Region (2018-2029)
  • Figure 81. Middle East Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 82. Africa Intradermal Injection Device Revenue (2018-2029) & (US$ Million)
  • Figure 83. Intradermal Injection Device Value Chain
  • Figure 84. Distributors Profiles
  • Figure 85. Bottom-up and Top-down Approaches for This Report
  • Figure 86. Data Triangulation
  • Figure 87. Key Executives Interviewed
目次

The global Intradermal Injection Device market is projected to grow from US$ 109.10 million in 2023 to US$ 137.75 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.96% during the forecast period.

The US & Canada market for Intradermal Injection Device is estimated to increase from $ 19.79 million in 2023 to reach $ 24.09 million by 2029, at a CAGR of 3.33% during the forecast period of 2023 through 2029.

The China market for Intradermal Injection Device is estimated to increase from $ 15.64 million in 2023 to reach $ 23.51 million by 2029, at a CAGR of 7.03% during the forecast period of 2023 through 2029.

The Europe market for Intradermal Injection Device is estimated to increase from $ 22.82 million in 2023 to reach $ 28.16 million by 2029, at a CAGR of 3.56% during the forecast period of 2023 through 2029.

The global key manufacturers of Intradermal Injection Device include: Terumo, BD, NanoPass Technologies, Idevax, Debiotech, PharmaJet, and Debiotech, etc. In 2022, the global top five players had a share approximately 84.02% in terms of revenue.

Report Includes:

This report presents an overview of global market for Intradermal Injection Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Intradermal Injection Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intradermal Injection Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intradermal Injection Device sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Intradermal Injection Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Intradermal Injection Device sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Terumo, BD, NanoPass Technologies, Idevax, Debiotech, PharmaJet, and Debiotech, etc.

By Company

  • Terumo
  • BD
  • NanoPass Technologies
  • Idevax
  • Debiotech
  • PharmaJet
  • Debiotech
  • Novosanis
  • HIPRA
  • Lightnix Inc

Segment by Type

  • Disposable
  • Reusable

Segment by Application

  • Vaccine
  • Medical Test
  • Others

Segment by Region

  • US & Canada
    • U.S.
    • Canada
  • China
  • Asia (excluding China)
    • Japan
    • South Korea
    • China Taiwan
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Middle East, Africa, Latin America
    • Brazil
    • Mexico
    • Turkey
    • Israel
    • GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Intradermal Injection Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Intradermal Injection Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intradermal Injection Device sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE

  • 1.1 Intradermal Injection Device Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Intradermal Injection Device Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Disposable
    • 1.2.3 Reusable
  • 1.3 Market by Application
    • 1.3.1 Global Intradermal Injection Device Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Vaccine
    • 1.3.3 Medical Test
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 EXECUTIVE SUMMARY

  • 2.1 Global Intradermal Injection Device Revenue Estimates and Forecasts 2018-2029
  • 2.2 Global Intradermal Injection Device Revenue by Region
    • 2.2.1 Global Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Intradermal Injection Device Revenue by Region (2018-2023)
    • 2.2.3 Global Intradermal Injection Device Revenue by Region (2024-2029)
    • 2.2.4 Global Intradermal Injection Device Revenue Market Share by Region (2018-2029)
  • 2.3 Global Intradermal Injection Device Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Intradermal Injection Device Sales by Region
    • 2.4.1 Global Intradermal Injection Device Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Intradermal Injection Device Sales by Region (2018-2023)
    • 2.4.3 Global Intradermal Injection Device Sales by Region (2024-2029)
    • 2.4.4 Global Intradermal Injection Device Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 Asia-Pacific
  • 2.8 Latin America
  • 2.9 Middle East & Africa

3 COMPETITION BY MANUFACTURERS

  • 3.1 Global Intradermal Injection Device Sales by Manufacturers
    • 3.1.1 Global Intradermal Injection Device Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Intradermal Injection Device Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 3 and Top 5 Largest Manufacturers of Intradermal Injection Device in 2022
  • 3.2 Global Intradermal Injection Device Revenue by Manufacturers
    • 3.2.1 Global Intradermal Injection Device Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Intradermal Injection Device Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 3 and Top 5 Companies by Intradermal Injection Device Revenue in 2022
  • 3.3 Global Key Players of Intradermal Injection Device, Industry Ranking, 2021 VS 2022
  • 3.4 Global Intradermal Injection Device Sales Price by Manufacturers (2018-2023)
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Intradermal Injection Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Intradermal Injection Device, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Intradermal Injection Device, Product Offered and Application
  • 3.8 Global Key Manufacturers of Intradermal Injection Device, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

  • 4.1 Global Intradermal Injection Device Sales by Type
    • 4.1.1 Global Intradermal Injection Device Historical Sales by Type (2018-2023)
    • 4.1.2 Global Intradermal Injection Device Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Intradermal Injection Device Sales Market Share by Type (2018-2029)
  • 4.2 Global Intradermal Injection Device Revenue by Type
    • 4.2.1 Global Intradermal Injection Device Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Intradermal Injection Device Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Intradermal Injection Device Revenue Market Share by Type (2018-2029)
  • 4.3 Global Intradermal Injection Device Price by Type
    • 4.3.1 Global Intradermal Injection Device Price by Type (2018-2023)
    • 4.3.2 Global Intradermal Injection Device Price Forecast by Type (2024-2029)

5 MARKET SIZE BY APPLICATION

  • 5.1 Global Intradermal Injection Device Sales by Application
    • 5.1.1 Global Intradermal Injection Device Historical Sales by Application (2018-2023)
    • 5.1.2 Global Intradermal Injection Device Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Intradermal Injection Device Sales Market Share by Application (2018-2029)
  • 5.2 Global Intradermal Injection Device Revenue by Application
    • 5.2.1 Global Intradermal Injection Device Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Intradermal Injection Device Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Intradermal Injection Device Revenue Market Share by Application (2018-2029)
  • 5.3 Global Intradermal Injection Device Price by Application
    • 5.3.1 Global Intradermal Injection Device Price by Application (2018-2023)
    • 5.3.2 Global Intradermal Injection Device Price Forecast by Application (2024-2029)

6 US & CANADA

  • 6.1 US & Canada Intradermal Injection Device Market Size by Type
    • 6.1.1 US & Canada Intradermal Injection Device Sales by Type (2018-2029)
    • 6.1.2 US & Canada Intradermal Injection Device Revenue by Type (2018-2029)
  • 6.2 US & Canada Intradermal Injection Device Market Size by Application
    • 6.2.1 US & Canada Intradermal Injection Device Sales by Application (2018-2029)
    • 6.2.2 US & Canada Intradermal Injection Device Revenue by Application (2018-2029)
  • 6.3 US & Canada Intradermal Injection Device Market Size by Country
    • 6.3.1 US & Canada Intradermal Injection Device Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Intradermal Injection Device Revenue by Country (2018-2029)
    • 6.3.3 US & Canada Intradermal Injection Device Sales by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 EUROPE

  • 7.1 Europe Intradermal Injection Device Market Size by Type
    • 7.1.1 Europe Intradermal Injection Device Sales by Type (2018-2029)
    • 7.1.2 Europe Intradermal Injection Device Revenue by Type (2018-2029)
  • 7.2 Europe Intradermal Injection Device Market Size by Application
    • 7.2.1 Europe Intradermal Injection Device Sales by Application (2018-2029)
    • 7.2.2 Europe Intradermal Injection Device Revenue by Application (2018-2029)
  • 7.3 Europe Intradermal Injection Device Market Size by Country
    • 7.3.1 Europe Intradermal Injection Device Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Intradermal Injection Device Revenue by Country (2018-2029)
    • 7.3.3 Europe Intradermal Injection Device Sales by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 ASIA-PACIFIC

  • 8.1 Asia-Pacific Intradermal Injection Device Market Size by Type
    • 8.1.1 Asia-Pacific Intradermal Injection Device Sales by Type (2018-2029)
    • 8.1.2 Asia-Pacific Intradermal Injection Device Revenue by Type (2018-2029)
  • 8.2 Asia-Pacific Intradermal Injection Device Market Size by Application
    • 8.2.1 Asia-Pacific Intradermal Injection Device Sales by Application (2018-2029)
    • 8.2.2 Asia-Pacific Intradermal Injection Device Revenue by Application (2018-2029)
  • 8.3 Asia-Pacific Intradermal Injection Device Market Size by Region
    • 8.3.1 Asia-Pacific Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
    • 8.3.2 Asia-Pacific Intradermal Injection Device Revenue by Region (2018-2029)
    • 8.3.3 Asia-Pacific Intradermal Injection Device Sales by Region (2018-2029)
    • 8.3.4 China
    • 8.3.5 Japan
    • 8.3.6 South Korea
    • 8.3.7 India
    • 8.3.8 Southeast Asia-Pacific

9 LATIN AMERICA

  • 9.1 Latin America Intradermal Injection Device Market Size by Type
    • 9.1.1 Latin America Intradermal Injection Device Sales by Type (2018-2029)
    • 9.1.2 Latin America Intradermal Injection Device Revenue by Type (2018-2029)
  • 9.2 Latin America Intradermal Injection Device Market Size by Application
    • 9.2.1 Latin America Intradermal Injection Device Sales by Application (2018-2029)
    • 9.2.2 Latin America Intradermal Injection Device Revenue by Application (2018-2029)
  • 9.3 Latin America Intradermal Injection Device Market Size by Region
    • 9.3.1 Latin America Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Latin America Intradermal Injection Device Revenue by Country (2018-2029)
    • 9.3.3 Latin America Intradermal Injection Device Sales by Country (2018-2029)
    • 9.3.4 Mexico
    • 9.3.5 Brazil

10 MIDDLE EAST AND AFRICA

  • 10.1 Middle East and Africa Intradermal Injection Device Market Size by Type
    • 10.1.1 Middle East and Africa Intradermal Injection Device Sales by Type (2018-2029)
    • 10.1.2 Middle East and Africa Intradermal Injection Device Revenue by Type (2018-2029)
  • 10.2 Middle East and Africa Intradermal Injection Device Market Size by Application
    • 10.2.1 Middle East and Africa Intradermal Injection Device Sales by Application (2018-2029)
    • 10.2.2 Middle East and Africa Intradermal Injection Device Revenue by Application (2018-2029)
  • 10.3 Middle East and Africa Intradermal Injection Device Market Size by Region
    • 10.3.1 Middle East and Africa Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East and Africa Intradermal Injection Device Revenue by Country (2018-2029)
    • 10.3.3 Middle East and Africa Intradermal Injection Device Sales by Country (2018-2029)
    • 10.3.4 Middle East
    • 10.3.5 Africa

11 CORPORATE PROFILE

  • 11.1 BD
    • 11.1.1 BD Company Information
    • 11.1.2 BD Overview
    • 11.1.3 BD Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 BD Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 BD Recent Developments
  • 11.2 Terumo
    • 11.2.1 Terumo Company Information
    • 11.2.2 Terumo Overview
    • 11.2.3 Terumo Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Terumo Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Terumo Recent Developments
  • 11.3 HIPRA
    • 11.3.1 HIPRA Company Information
    • 11.3.2 HIPRA Overview
    • 11.3.3 HIPRA Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 HIPRA Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 HIPRA Recent Developments
  • 11.4 NanoPass Technologies
    • 11.4.1 NanoPass Technologies Company Information
    • 11.4.2 NanoPass Technologies Overview
    • 11.4.3 NanoPass Technologies Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 NanoPass Technologies Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 NanoPass Technologies Recent Developments
  • 11.5 Novosanis (Idevax)
    • 11.5.1 Novosanis (Idevax) Company Information
    • 11.5.2 Novosanis (Idevax) Overview
    • 11.5.3 Novosanis (Idevax) Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Novosanis (Idevax) Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Novosanis (Idevax) Recent Developments
  • 11.6 Idevax
    • 11.6.1 Idevax Company Information
    • 11.6.2 Idevax Overview
    • 11.6.3 Idevax Recent Developments
  • 11.7 PharmaJet
    • 11.7.1 PharmaJet Company Information
    • 11.7.2 PharmaJet Overview
    • 11.7.3 PharmaJet Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 PharmaJet Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 PharmaJet Recent Developments
  • 11.8 Debiotech
    • 11.8.1 Debiotech Company Information
    • 11.8.2 Debiotech Overview
    • 11.8.3 Debiotech Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Debiotech Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9 Lightnix Inc
    • 11.9.1 Lightnix Inc Company Information
    • 11.9.2 Lightnix Inc Overview
    • 11.9.3 Lightnix Inc Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

  • 12.1 Intradermal Injection Device Industry Chain Analysis
  • 12.2 Intradermal Injection Device Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Intradermal Injection Device Production Mode & Process
  • 12.4 Intradermal Injection Device Sales and Marketing
    • 12.4.1 Intradermal Injection Device Distributors
  • 12.5 Intradermal Injection Device Customers

13 INTRADERMAL INJECTION DEVICE MARKET DYNAMICS

    • 13.1.1 Intradermal Injection Device Industry Trends
    • 13.1.2 Intradermal Injection Device Market Drivers
    • 13.1.3 Intradermal Injection Device Market Challenges
    • 13.1.4 Intradermal Injection Device Market Restraints

14 KEY FINDINGS IN THE GLOBAL INTRADERMAL INJECTION DEVICE STUDY

15 APPENDIX

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer